{
    "eid": "2-s2.0-85062528852",
    "title": "Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi-Gouti\u00e8res Syndrome, a Type I Interferonopathy",
    "cover-date": "2019-05-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Rheumatology",
            "@code": "2745",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [],
    "authors": [
        "Kornvalee Meesilpavikkai",
        "Willem A. Dik",
        "Benjamin Schrijver",
        "Cornelia G. van Helden-Meeuwsen",
        "Marjan A. Versnel",
        "P. Martin van Hagen",
        "Emilia K. Bijlsma",
        "Claudia A.L. Ruivenkamp",
        "Margreet J. Oele",
        "Virgil A.S.H. Dalm"
    ],
    "citedby-count": 35,
    "ref-count": 10,
    "ref-list": [
        "Aicardi-Goutieres syndrome and the type I interferonopathies",
        "Clinical and molecular phenotype of Aicardi-Goutieres syndrome",
        "Aicardi-Goutieres syndrome: a model disease for systemic autoimmunity",
        "Interferon-stimulated gene expression as a preferred biomarker for disease activity in Aicardi-Goutieres syndrome",
        "Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study",
        "Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children",
        "Baricitinib treatment in a patient with a gain-of-function mutation in signal transducer and activator of transcription 1 (STAT1)",
        "Familial Aicardi-Goutieres syndrome due to SAMHD1 mutations is associated with chronic arthropathy and contractures",
        "Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression",
        "Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases"
    ],
    "affiliation": [
        {
            "affiliation-city": "Rotterdam",
            "@id": "60032114",
            "affilname": "Erasmus MC",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032114",
            "affiliation-country": "Netherlands"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Leidschendam",
            "@id": "60026091",
            "affilname": "HMC",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026091",
            "affiliation-country": "Netherlands"
        },
        {
            "affiliation-city": "Leiden",
            "@id": "60015618",
            "affilname": "Leids Universitair Medisch Centrum",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015618",
            "affiliation-country": "Netherlands"
        }
    ],
    "funding": [
        "Chulalongkorn University Faculty of Medicine, Bangkok, Thailand",
        "Erasmus University Medical Center"
    ]
}